Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.162,62
-0,05%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NeuroMetrix Inc (NURO) NeuroMetrix Inc (NURO) Notizie

NeuroMetrix Inc

NURO
3,90
0,00 (0,00%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202416:24EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
18/12/202415:03PRNUSKuehn Law Encourages PWOD, NURO, BHLB, and BRKL Investors to..
17/12/202423:27EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/12/202423:25EDGAR2Form 8-K - Current report
17/12/202422:05GLOBENeuroMetrix to be Acquired by electroCore
05/11/202422:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202413:12EDGAR2Form 8-K - Current report
05/11/202413:00GLOBENeuroMetrix Reports Q3 2024 Business Highlights
02/10/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202421:56EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
26/9/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202420:47GLOBENeuroMetrix Reiterates its Review of Strategic Alternatives
06/8/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202413:16EDGAR2Form 8-K - Current report
06/8/202413:00GLOBENeuroMetrix Reports Q2 2024 Business Highlights and Update..
31/7/202420:03GLOBENeuroMetrix, Inc. Announces Date for Second Quarter 2024..
31/5/202419:15EDGAR2Form SD - Specialized disclosure report
24/5/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202422:00GLOBENeuroMetrix Reports Q1 2024 Business Highlights
15/5/202418:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/5/202417:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/4/202414:00GLOBENeuroMetrix Announces Steps Taken to Enhance Shareholder..
14/3/202414:00GLOBENeuroMetrix Announces Publication of Study Demonstrating..
13/3/202414:00GLOBENeuroMetrix announces that over 2000 patients with..
06/3/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:12EDGAR2Form SC 13D/A - General statement of acquisition of..
01/3/202423:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202422:45EDGAR2Form 8-K/A - Current report: [Amend]
27/2/202422:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
26/2/202423:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22/2/202413:15EDGAR2Form 8-K - Current report
22/2/202413:00GLOBENeuroMetrix Reports Q4 and Full Year 2023 Business..
20/2/202420:49EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
15/2/202415:00GLOBENeuroMetrix, Inc. Announces Date for Fourth Quarter and Full..
13/2/202415:00GLOBENeuroMetrix Announces Review of Strategic Options to Promote..
Apertura: 3,9474 Min: 3,80 Max: 4,005
Chiusura: 3,90

La tua Cronologia

NASDAQ
NURO
NeuroMetrix
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network